ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 265875 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 265875; 2) Community: the network communities that were significantly associated with the response to NSC 265875; 3) Molecule: the relationships between components within communities and NSC 265875; 4) MDR: the compounds that were significantly associated with the NSC 265875.

NSC Compound Enrichment Correlation
NSC 755412 Null 0.0303734648501639 0.15187059
NSC 755431 Null 0.0303734648501639 0.06475296
NSC 756323 GW701427A 0.0303734648501639 0.1071477
NSC 760183 tert-butyl 2-((6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate 0.0303734648501639 -0.060824886
NSC 83321 Null 0.0303734648501639 -0.026082898
NSC 86368 Null 0.0303734648501639 0.27250738
NSC 364830 Camptothecin Derivative 0.0304779558345019 0.046730985
NSC 382050 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)- 6-ethyl-, monoethanesulfonate 0.0304779558345019 0.093533745
NSC 46691 Null 0.0304779558345019 -0.044931274
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.0304779558345019 0.16131508
Total:86  Current:62    [First] [Prev] [Next] [Last]